Vironix Health Inc.

AI-Enabled Early Detection and Remote Monitoring of Lung and Heart Disease

Print
Claim My Business
Security Type
Preferred Stock
Categories
Technology, Infrastructure, Healthcare & Medical, Community & Lifestyle
Min Investment
$250
Location
Austin, TX
Expected Close Date
April 30, 2023
Target Raise
$50.01K-$1.07M
No. Investors
193
Security Price
$13.19
Valuation
$14,900,000
Website
vironix.ai
Number of Employees
3
Cash
$103,621
Revenue
$2,408
Short Term Debt
$10,910
Cost of Goods
$0
Long Term Debt
$289,726
Net Income
$-141,223

Key Deal Facts

❤️ Vironix Outperforms Standard-of-Care in Detecting/Triaging Heart Failure, COPD & Asthma Flare-ups
💸 $150M Potential ARR from Current LOIs (not guaranteed)
💪 APIs Raise Wellness, Scale Globally, & Grow Revenue for Caregivers
💰 $450K Raised in Pre-Seed/Seed capital to date; $350K Invested Into R&D
🤝 World Class R&D Collaboration w/ Oxford University
📜 Patent Pending on Early Detection Technology (USPTO: 63/316,078)
🎓 2021 Mass Challenge Accelerator Alum & ✊ Certified Minority Controlled Enterprise
📖 Peer-Reviewed Publications and Invited Talks w/ Duke, Kaiser-Permanente, & Oxford.

Management Team / Advisory Board Bios

Sumanth Swaminathan, PhD CoFounder & CEOOver a decade of AI-healthcare product development & commercialization experience as a technology consultant, chief data scientist, and CEO: NSF SBIR winner, MassChallenge 2021 alum, >50 peer-reviewed & proceeding papers, Northwestern PhD, Oxford Postdoc., Sriram Ramanathan, MS CoFounder & Chief Technology Officer A technology executive with more than 25 years of cutting edge experience in the mobile, AI, cloud computing and telecommunications domains: CTO of Kony (acquired by Temenos for $560M) ; SVP at Oracle, Distinguished IBM Engineer (>150 patents), Christopher Landon M.D. CoFounder & Medical Specialist: PulmonologyDirector of Pediatrics at Ventura County Medical Center ; Clinical Assistant Professor of Family Medicine at UCLA ; Clinical Associate Professor of Pediatrics at USC ; Directed large population studies and physician education on COPD, Asthma, & CF, Botros Toro, PhD CoFounder & Product Architect After escaping the 2011 Syrian crisis, Dr. Toro completed a PhD in Biology from U. Albany, graduated the eminent Data Incubator NYC (2% acceptance rate), & Cofounded Vironix Health: Mass Challenge 2021 alum and decorated machine-learning scientist., Mahesh Visvanathan, MBA Chief Business Development Officer A customer focused executive with over 25 years of experience managing operations and transformations for healthcare technology-based services: SVP at Truven (acquired by IBM for $2.B); VP at Anthem, SVP at IBM, U. Mich MBA., Nicholas Wysham M.D. CoFounder & Medical Specialist: PulmonologyA practicing pulmonologist, partner, and board member of The Vancouver Clinic in Vancouver, WA ; Clinical Associate Professor of Medicine at WSU ; Pulmonary Critical Care Fellowship at Duke., Emani Kelley Clinical Research SpecialistProject coordinator for studies spanning clinical drug trials to innovative devices and new breakthrough methodologies: 2019 Fulbright Scholar ; B.A. in Psychology with minors in Spanish and Latin American Studies from College of Wooster, OH., Jatin Rajput, MBA Senior Strategic Advisor: Bus Dev & FundraisingOver 20 years of experience investing, managing and growing financial services and technology businesses in both developed and emerging markets: Partner at Union Park Ventures ; Founder at Ad-in-Ventures, MBA from Insead, Blockchain Bus Cert from MIT, Mahesh Tirupattur Senior Strategic Advisor: Sales & Bus DevOver 25 years of entrepreneurship and executive experience in sales, marketing and business development: CoFounder & COO/EVP at Analog Bits ; CoFounder & VP Sales at Virtual Silicon, Jeffrey Hanson, M.P.H., M.Ed., B.S. Senior Global Healthcare AdvisorA healthcare executive with a thirty-five year career working in the healthcare consulting, digital information technology, analytics, and services industry: President of Maine, New England, and National Rural Health Associations ; VP IBM Watson health, Krish Kumar Senior Strategic Advisor 25+ years experience as an IT and Business Executive, Krish builds Customer relationships, accelerates revenue with profitable growth, enables operational efficiency, regulatory compliance by leveraging digital and business transformations., MARAT FUDIM, M.D Medical Advisor - Heart Failure SpecialistPracticing cardiologist and Heart Failure specialist with over ten years of patient care, and research experience. Director of Duke University Remote Monitoring Clinic. MD at U. Dusseldorf. Residency at Vanderbilt. Fellowship at Duke University., Andrew P Ambrosy M.D. Medical Advisor - Heart Failure SpecialistPracticing cardiologist and clinician-investigator at Kaiser Permanente in San Francisco Medical Center. Regional Director at KP Northern California Division of Research. MD at Northwestern. Residency at Stanford. Fellowship at Duke., Shadin Hilton, MS, MBA, RNC, NE-BC, PMP Senior Global Healthcare AdvisorOver 23 years of experience in hospital administration, operations, program mgmt, & consulting. Director: Patient Care Services, Baylor Medical Center ; Healthcare Consultant: John Hopkins Med Intl ; Senior Consultant: IBM Watson Health, Christopher Chew Growth & Fundraising AdvisorAn engineer, investor, and awarded innovator. Early product development work at NASA and Gore-Tex. Start-up building experience, including companies like Bloomscape and Modern Meadow., Viji Swaminathan Ph.D. Research Grants Specialist Research scientist & technologist with a background in physics, biochemistry, and computer science. Ph.D. in Physics from University of Madras, India. MS in Computer Science from West Chester University., Govind Shantharam Medical & Strategic Business AdvisorResident physician at the Icahn School of Medicine at Mt. Sinai. MD at Brown University. BA at UC Berkeley in Health Economics & Policy, and Philosophy.
Amount Raised : $944,519
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Preferred securities are a type of investment that generally offers some sort of preferred treatment through a dividend or preferred treatment in a liquidation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments